沃恩贝（苏州）洁净科技有限公司
20人以下
公司优势
20,861+ 岗位更新等你来订阅
一键订阅最新的岗位，每周送达
🎉恭喜你，订阅成功
继续订阅您可以在邮箱中随时取消订阅
Advanced Energy Industries, Inc., established in 1981 with headquarters in Colorado, is an international, diversified company listed on the NASDAQ stock market (ticker: AEIS). Committed to providing global customers with perfected power solutions for complex applications, AE's offerings span semiconductor equipment, industry, manufacturing, telecommunications, data center computing, and healthcare sectors. By strategically acquiring businesses to expand its product portfolio and power technology, AE facilitates design innovations and propels the growth of its clients. For more detailed information about the company, please visit our official website.
With operations in over 60 countries and a workforce exceeding 10,000 employees worldwide, Advanced Energy seeks to enhance its business through strategic acquisitions. Our employee-centric management model, competitive compensation packages, and comprehensive training programs offer ample opportunities for personal development. We invite potential candidates to submit their resumes!
Here is a brief overview of Advanced Energy's China-based subsidiaries:
- **Advanced Energy Power Products (Shenzhen) Co., Ltd., Advanced Energy Electronics Co., Ltd., and their Beijing and Xi'an branches** focus on developing and providing high-power switching power supplies, server power supplies, medical power supplies, and modular power supplies, along with post-sales services.
- **Uvi Semiconductor Equipment Co., Ltd.,** with offices in Shenzhen, Shanghai, and Xi'an, specializes in sales and post-sales maintenance of power supplies used in plasma-related processes such as film deposition and etching under plasma conditions.
文山市云鑫传媒有限公司，公司规模为少于50人，公司类型为民营公司，所属行业为计算机软件。
深圳市鑫聚源供应链管理有限公司诚聘
吾悦广场三楼 红娘顾问
武汉睿健医药是全球专注于高效化学小分子诱导功能细胞再生的高科技制药公司，由剑桥大学和爱丁堡大学归国人员创立。睿健医药专注于新一代化学诱导的细胞治疗产品的开发，旨在为“无法治愈”的疾病提供全新的解决方案。作为纯化学诱导的细胞重建专家，睿健医药纯化学诱导系统可以轻松重建得到高纯度的人类细胞类型，而无需对细胞进行基因组修饰。睿健医药的针对帕金森病的管线 NouvNeu001计划于 2022 年第一季度之前提交 IND 申请。
睿健医药在武汉光谷拥有4000平米研发生产基地，其中包括符合国际生产标准的全新“B+A”级生产车间，以及全装备分子生物学、细胞生物学及质谱分析平台。目前，武汉睿健自主知识产权的化学诱导的药物管线覆盖神经退行性疾病、代谢系统疾病、遗传病及罕见病等多个领域。系列产品针对国际老龄化趋势，且神经修复领域中尚无药物可以治愈退行性疾病，因此具备领先的国际优势。武汉睿健医药陆续获得国家人社部重点项目、英国“EPSRC 产业战略创新”项目等工业创新项目支持。